The FDA has warned that ketamine and compounded ketamine products aren’t approved to take care of any psychiatric disorder. This usually means that they haven’t been tested to become safe or powerful. In 2019, the FDA approved a nasal spray called esketamine (Spravato) that’s derived from ketamine for treatment-resistant depression, https://mayaw111siv9.wikimillions.com/user